These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36414219)

  • 21. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis.
    Bergantini L; d'Alessandro M; Cameli P; Otranto A; Luzzi S; Bianchi F; Bargagli E
    Cytokine; 2022 Mar; 151():155804. PubMed ID: 35063722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
    Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
    Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
    Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
    Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.
    Elbadawy HM; Khattab A; El-Agamy DS; Eltahir HM; Alhaddad A; Aljohani FD; Almuzaini TM; Abouzied MM; Aldhafiri A
    J Clin Lab Anal; 2023 Apr; 37(7):e24881. PubMed ID: 37096731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IP-10 and complement activation as friend or foe in COVID-19.
    Bunprakob S; Hemachudha P; Ruchisrisarod C; Supharatpariyakorn T; Hemachudha T
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096202. PubMed ID: 35531750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory Markers, Pulmonary Function, and Clinical Symptoms in Acute COVID-19 Among Non-Hospitalized Adolescents and Young Adults.
    Lund Berven L; Selvakumar J; Havdal L; Stiansen-Sonerud T; Einvik G; Leegaard TM; Tjade T; Michelsen AE; Mollnes TE; Wyller VBB
    Front Immunol; 2022; 13():837288. PubMed ID: 35222429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis.
    Qin R; He L; Yang Z; Jia N; Chen R; Xie J; Fu W; Chen H; Lin X; Huang R; Luo T; Liu Y; Yao S; Jiang M; Li J
    Clin Rev Allergy Immunol; 2023 Feb; 64(1):33-65. PubMed ID: 35040086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.
    Bergantini L; d'Alessandro M; Gangi S; Bianchi F; Cameli P; Perea B; Meocci M; Fabbri G; Marrucci S; Ederbali M; Bargagli E
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.
    Kozma GT; Mészáros T; Bakos T; Hennies M; Bencze D; Uzonyi B; Győrffy B; Cedrone E; Dobrovolskaia MA; Józsi M; Szebeni J
    Front Immunol; 2021; 12():642860. PubMed ID: 33995361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce.
    Laudanski K; Okeke T; Siddiq K; Hajj J; Restrepo M; Gullipalli D; Song WC
    Sci Rep; 2022 Aug; 12(1):13658. PubMed ID: 35953544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulatory Cytokine Levels as a Predictor of Disease Severity in COVID-19: A Study from Western India.
    Bhandari S; Rankawat G; Mathur S; Kumar A; Sahlot R; Jain A
    J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
    Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of polymorphisms in long pentraxin 3 and its plasma levels with COVID-19 severity.
    Feitosa TA; de Souza Sá MV; Pereira VC; de Andrade Cavalcante MK; Pereira VRA; da Costa Armstrong A; do Carmo RF
    Clin Exp Med; 2023 Aug; 23(4):1225-1233. PubMed ID: 36315310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].
    Salman E; Çelikbilek N; Aydoğan S; Özdem B; Gökay S; Kırca F; Toyran A; Bilici Salman R; Dinç B
    Mikrobiyol Bul; 2021 Oct; 55(4):539-552. PubMed ID: 34666654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.